Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.

Ciepłuch, Hanna

Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma. [electronic resource] - Medical science monitor : international medical journal of experimental and clinical research Apr 2002 - PI31-6 p. digital

Publication Type: Clinical Trial; Journal Article

1234-1010


Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Constipation--chemically induced
Diphosphonates--administration & dosage
Disorders of Excessive Somnolence--chemically induced
Dizziness--chemically induced
Drug Resistance, Neoplasm
Female
Humans
Male
Middle Aged
Multiple Myeloma--blood
Myeloma Proteins--analysis
Osteolysis--drug therapy
Pain--drug therapy
Pamidronate
Remission Induction
Thalidomide--administration & dosage
Treatment Outcome